Heart failure & cardiomyopathies
Strategies for preventing and reversing atrial cardiomyopathy: current evidence, therapeutic targets, and future directions. A European Journal of Heart Failure expert consensus statement
Scope
As issued by the authors
Natural history, determinants and therapeutic modification of atrial cardiomyopathy (AtCM): lifestyle and comorbidity management, pharmacological and structural interventions for heart failure (HF) and valve disease, rhythm control in atrial fibrillation (AF), emerging atrial-directed therapies, and evidence gaps
Original publication
Strategies for preventing and reversing atrial cardiomyopathy: current evidence, therapeutic targets, and future directions. A European Journal of Heart Failure expert consensus statement. Eur J Heart Fail. Published 19 August 2026. doi:10.
Summarised from the published abstract; every number is checked against it